Sciensano

Infectious Disease Immunology

Research activity centers on SARS-CoV-2 immunity, with attention to binding antibodies and neutralizing antibodies against circulating variants of concern.

  • Viral immunity surveillance
  • Variant-specific antibody responses
  • Population-level immune monitoring

The clinical focus includes repeated assessment of immune status in relation to the epidemiologically predominant COVID-19 variant.

Immunocompromised Populations

The sponsor’s research interest includes immunocompromised patients, especially nursing home residents, dialysis patients, and kidney transplant and lung transplant recipients.

  • Transplant medicine
  • Dialysis care
  • Long-term care populations

These groups are followed alongside healthy adults to characterize differences in immune protection across age and clinical vulnerability.

Longitudinal Cohort Research

Clinical research is organized around prospective cohort follow-up in Belgium, with repeated immune assessments across multiple collaborating sites.

  • Multicenter observational research
  • Repeated serological assessment
  • Real-world immune tracking

This work supports ongoing monitoring of immune responses over time in adults from 18 to 105 years of age.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium